Iodine status in a population is best measured using which of the following?
For every 100,000 population, which region of the world has the highest prevalence of blindness?
The 'Rule of Halves' is most prominently observed in which of the following conditions?
Height in centimeters divided by the cube root of body weight is also known as which index?
What is the primary method for the control of tuberculosis and leprosy?
The 17D vaccine is used for the prevention and control of which disease?
What is the drug of choice for treating cholera in a pregnant woman?
What is the recommended immunization schedule for IPV?
What is the rickettsial agent of Epidemic typhus?
All of the following are true about varicella EXCEPT?
Explanation: ### Explanation **Correct Option: D. Urinary iodine levels** **Why it is correct:** Urinary Iodine Excretion (UIE) is the most sensitive and reliable indicator for assessing the iodine status of a **population**. Since approximately 90% of dietary iodine is excreted through the kidneys, urinary levels directly reflect recent dietary intake. For epidemiological surveys, a **median urinary iodine concentration (MUIC)** is used: * **Optimal:** 100–199 µg/L * **Deficiency:** <100 µg/L * **Excess:** >300 µg/L **Why other options are incorrect:** * **A & B (TSH, T3, T4):** While these are vital for diagnosing individual thyroid dysfunction (hypothyroidism/hyperthyroidism), they are poor indicators of population iodine status. Serum TSH is only sensitive for iodine status in **neonates**, not the general population. T3 and T4 levels often remain within normal limits even in moderate iodine deficiency due to compensatory mechanisms. * **C (Thyroglobulin):** This is a sensitive marker for long-term iodine nutrition in children and adults, but it is technically difficult to measure and lacks the standardized global reference ranges that make Urinary Iodine the "gold standard" for public health monitoring. **High-Yield NEET-PG Pearls:** 1. **Neonatal TSH:** The best indicator for monitoring the impact of iodine deficiency on the **developing brain** in a community. 2. **Goiter Rate:** A Total Goiter Rate (TGR) of **>5%** in primary school children (6–12 years) signifies that iodine deficiency is a public health problem in that area. 3. **Iodized Salt:** Under the National Iodine Deficiency Disorders Control Programme (NIDDCP), salt must contain **30 ppm** of iodine at the production level and **15 ppm** at the consumer level. 4. **Standard Test:** The **Sandell-Kolthoff reaction** is the analytical method used to measure urinary iodine.
Explanation: **Explanation:** The prevalence of blindness is a critical indicator of a region's socioeconomic status and the robustness of its healthcare infrastructure. According to global data from the World Health Organization (WHO) and the International Agency for the Prevention of Blindness (IAPB), **Sub-Saharan Africa** consistently reports the highest age-standardized prevalence of blindness (approximately 1.0% to 1.2% of the population). **1. Why Sub-Saharan Africa is Correct:** The high prevalence is attributed to a "double burden" of disease. While age-related conditions like **cataracts** remain the leading cause, the region also faces significant challenges from infectious causes such as **trachoma** and **onchocerciasis** (river blindness). Limited access to surgical interventions, a shortage of ophthalmologists, and poor nutritional status (Vitamin A deficiency) further exacerbate the statistics. **2. Analysis of Incorrect Options:** * **South Asia:** While South Asia (including India) has the **highest absolute number** of blind individuals due to its massive population size, the *prevalence rate* per 100,000 is lower than in Sub-Saharan Africa due to improving eye-care programs (e.g., NPCB in India). * **Eastern Europe & Latin America:** These regions have more developed healthcare systems and higher surgical coverage for cataracts, leading to significantly lower prevalence rates compared to the African continent. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of blindness (World & India):** Cataract. * **Most common cause of preventable blindness (World):** Trachoma. * **WHO Definition of Blindness:** Visual acuity <3/60 in the better eye with best possible correction. * **VISION 2020:** The global initiative "The Right to Sight" aims to eliminate avoidable blindness.
Explanation: **Explanation:** The **'Rule of Halves'** is a classic epidemiological concept used to describe the "iceberg phenomenon" in **Hypertension**. It highlights the significant gap between the prevalence of the disease and its effective management in the community. **The Rule of Halves states that:** * **Half** of the people with high blood pressure are **not known** (undiagnosed). * **Half** of those known to have hypertension are **not on treatment**. * **Half** of those treated are **not adequately controlled**. This rule underscores that only about 12.5% (1/8th) of the total hypertensive population actually achieves the target blood pressure, making it a vital concept for public health interventions. **Analysis of Incorrect Options:** * **A. Congenital Heart Disease (CHD):** These are structural defects present at birth. While many go undiagnosed, they do not follow a specific "Rule of Halves" pattern; diagnosis usually depends on clinical severity and screening. * **C. Blindness:** Epidemiological patterns in blindness are usually categorized by etiology (e.g., Cataract, Glaucoma, Refractive errors) and the "avoidable" vs. "unavoidable" fractions, rather than the Rule of Halves. * **D. Accidents and Injuries:** These are acute events. Public health focus here is on the "Haddon’s Matrix" or the "Epidemiological Triad," not the Rule of Halves. **High-Yield Clinical Pearls for NEET-PG:** * **Iceberg Phenomenon:** Hypertension is a classic example. The "Tip" represents diagnosed cases; the "Submerged portion" represents undiagnosed/asymptomatic cases. * **Tracking:** A phenomenon where children maintain their BP percentile rank as they grow into adulthood (a predictor of adult hypertension). * **Primary Prevention:** Population strategy (reducing salt intake, physical activity) is often more effective than the high-risk strategy for hypertension.
Explanation: **Explanation:** The correct answer is **C. Ponderal Index**. The **Ponderal Index (PI)**, also known as the Rohrer's Index, is a measure of leanness or "corpulence" of a person. It is calculated using the formula: $$\text{Ponderal Index} = \frac{\text{Height (cm)}}{\sqrt[3]{\text{Weight (kg)}}}$$ Unlike the Body Mass Index (BMI), which scales weight to the square of height, the Ponderal Index uses the cube root, making it more mathematically valid for assessing body composition across different heights, especially in newborns and pediatrics. **Analysis of Incorrect Options:** * **A. Quetelet Index:** This is the most common synonym for **Body Mass Index (BMI)**. It is calculated as $\text{Weight (kg)} / \text{Height (m)}^2$. It is the gold standard for epidemiological studies of obesity. * **B. Broca Index:** A simple formula used to estimate "Ideal Body Weight." It is calculated as: $\text{Height (cm)} - 100$. (e.g., if height is 170 cm, ideal weight is 70 kg). * **D. Corpulence Index:** While sometimes used interchangeably with Ponderal Index in older literature, in modern nutritional assessment, the Corpulence Index (or Kaup Index) specifically refers to the formula $\text{Weight (g)} / \text{Height (cm)}^2$, often used in infants. **High-Yield Clinical Pearls for NEET-PG:** * **Lorentz’s Formula:** A more refined version of the Broca index: $\text{Height (cm)} - 100 - [(\text{Height} - 150) / 4 \text{ (for males) or } 2 \text{ (for females)}]$. * **Best indicator of overweight in children:** BMI-for-age (Z-scores). * **Waist-Hip Ratio (WHR):** A WHR $>0.9$ in men and $>0.85$ in women indicates upper body (android) obesity and increased cardiovascular risk. * **Most sensitive marker of central obesity:** Waist circumference.
Explanation: **Explanation:** The primary strategy for controlling chronic infectious diseases like Tuberculosis (TB) and Leprosy is **Early Diagnosis and Treatment**. This approach is based on the epidemiological principle of **Secondary Prevention**, which aims to halt disease progression in the individual and reduce the "pool of infection" in the community. 1. **Why Option C is Correct:** Both TB and Leprosy have long incubation periods and are transmitted via prolonged contact. By identifying cases early (via sputum microscopy/NAAT for TB or skin examination for Leprosy) and initiating prompt chemotherapy (DOTS for TB; MDT for Leprosy), the patient rapidly becomes non-infectious. This breaks the chain of transmission, effectively controlling the spread. 2. **Why Other Options are Incorrect:** * **Isolation (A):** Historically used (Sanatoriums), but no longer practical or necessary. Modern chemotherapy renders patients non-infectious within days to weeks, making home-based treatment the standard. * **Specific Protection (B):** While the BCG vaccine exists, its efficacy in preventing adult pulmonary TB is variable, and there is no primary vaccine for Leprosy (though BCG offers some cross-protection). Thus, it is not the *primary* control method. * **Elimination of Reservoirs (D):** Humans are the only significant reservoir for both diseases. "Elimination" of the reservoir would mean curing every single case; therefore, early diagnosis and treatment is the *tool* used to achieve this goal. **High-Yield Clinical Pearls for NEET-PG:** * **TB:** The goal of the National TB Elimination Program (NTEP) is to end TB by **2025** in India. * **Leprosy:** A case is "released from treatment" (RFT) after completing MDT. The main indicator for leprosy control is the **New Case Detection Rate (NCDR)**. * **Key Concept:** For most communicable diseases without an effective mass vaccine, **Case Finding** is the backbone of control.
Explanation: **Explanation:** **Yellow Fever (Option A)** is the correct answer. The **17D vaccine** is a live-attenuated preparation derived from the 17D strain of the Yellow Fever virus. It is considered one of the most effective vaccines ever developed, providing long-lasting immunity (often lifelong) after a single subcutaneous dose. **Analysis of Incorrect Options:** * **Japanese Encephalitis (Option B):** Vaccines for JE include the live-attenuated **SA 14-14-2** strain (most common in India), or inactivated vaccines like JENVAC or IXIARO. * **Hemorrhagic Fever (Option C):** This is a broad category. While Yellow Fever is a type of viral hemorrhagic fever, the 17D vaccine is specific only to the Yellow Fever virus. Other hemorrhagic fevers (like Ebola or Lassa) require different specific vaccines or have none available. * **Dengue (Option D):** The most recognized vaccine is **Dengvaxia (CYD-TDV)**, which is a tetravalent live-attenuated vaccine. **High-Yield Clinical Pearls for NEET-PG:** * **Administration:** Given as a single dose (0.5 ml) subcutaneously. * **Validity:** Under International Health Regulations (IHR), the certificate of vaccination becomes valid **10 days** after vaccination and is now valid for **life**. * **Contraindications:** It is contraindicated in infants <6 months, individuals with egg allergies (as it is grown in chick embryos), and immunocompromised patients. * **Cold Chain:** It is highly heat-sensitive and must be stored between **+2°C to +8°C**.
Explanation: **Explanation:** The primary goal in treating Cholera is rehydration; however, antibiotics are used as an adjunct to reduce the duration of diarrhea and the volume of stool output. **1. Why Furazolidone is the Correct Answer:** In pregnant women, the standard drugs used for Cholera (Tetracyclines) are contraindicated due to their potential effects on fetal bone and tooth development. **Furazolidone** is considered the drug of choice in pregnancy because it is effective against *Vibrio cholerae* and has a proven safety profile for the fetus. **2. Analysis of Incorrect Options:** * **Tetracycline & Doxycycline (Options A & B):** While Doxycycline is the overall drug of choice for adults (including non-pregnant women), both are contraindicated in pregnancy. They cross the placenta and can cause permanent tooth discoloration and enamel hypoplasia in the fetus. * **Cotrimoxazole (Option D):** While it can be used in children, it is generally avoided in the first trimester (folate antagonist) and near term (risk of kernicterus) in pregnancy. It is not the primary recommendation for Cholera in this population. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice (General/Adults):** Doxycycline (300 mg single dose). * **Drug of Choice (Children):** Azithromycin (preferred) or Cotrimoxazole. * **Drug of Choice (Pregnancy):** Furazolidone (100 mg four times daily for 3 days). * **Chemoprophylaxis:** Not recommended for the general community; only for close household contacts. Doxycycline is used for prophylaxis. * **Public Health Note:** The most important step in Cholera management is **Fluid Replacement** (ORS for mild/moderate, Ringer’s Lactate for severe dehydration). Antibiotics are secondary.
Explanation: In the context of the National Immunization Schedule (NIS) in India, the correct answer is **6 and 14 weeks**. ### **Explanation of the Correct Answer** The Government of India introduced the **Fractional dose Inactivated Poliovirus Vaccine (fIPV)** into the routine immunization program to provide additional protection against Type 2 Poliovirus while transitioning away from Oral Polio Vaccine (OPV). * **The Schedule:** Two fractional doses (0.1 ml each) are administered **intradermally** at 6 weeks and 14 weeks. * **The Rationale:** Administering the second dose at 14 weeks (rather than 10 weeks) allows for a longer interval between doses, which significantly enhances the immune response and ensures better seroconversion rates. ### **Analysis of Incorrect Options** * **A (6 weeks):** A single dose is insufficient to provide adequate priming and long-term immunity against Polio. * **B (6 and 10 weeks):** While this provides two doses, the interval is too short. The 14-week mark is preferred to maximize the booster effect. * **D (6, 10, and 14 weeks):** While some global schedules (and the IAP) use a 3-dose primary series for full-dose IM-IPV, the current **National Immunization Schedule (NIS)** specifically mandates two fractional doses at 6 and 14 weeks to optimize resources and efficacy. ### **High-Yield Clinical Pearls for NEET-PG** * **Route:** fIPV is given **Intradermally (ID)**, usually on the right upper arm. * **Dose:** 0.1 ml (Fractional dose). Full-dose IM-IPV is 0.5 ml. * **Recent Update:** As of 2023, a **third dose** of fIPV has been introduced at **9 months** (along with MR-1) in several Indian states to further strengthen immunity. * **VVM:** IPV is highly heat-sensitive; always check the Vaccine Vial Monitor before administration.
Explanation: ### Explanation **Correct Answer: A. *Rickettsia prowazekii*** **1. Why it is correct:** Epidemic typhus (also known as Louse-borne typhus) is caused by ***Rickettsia prowazekii***. It is transmitted to humans by the **human body louse** (*Pediculus humanus corporis*). The bacteria are excreted in the louse's feces, and infection occurs when the feces are rubbed into bite wounds or mucous membranes. It is historically associated with crowded conditions, wars, and famine. **2. Why the other options are incorrect:** * **B. *R. typhi*:** This is the causative agent of **Endemic (Murine) typhus**, which is transmitted by the rat flea (*Xenopsylla cheopis*). * **C. *R. tsutsugamushi* (now *Orientia tsutsugamushi*):** This causes **Scrub typhus**, transmitted by the bite of larval mites (chiggers). It is characterized by the presence of an "eschar" at the bite site. * **D. *R. conorii*:** This causes **Indian Tick Typhus** (Boutonneuse fever), transmitted by the dog tick (*Rhipicephalus sanguineus*). **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Brill-Zinsser Disease:** This is a recrudescent (latent) form of Epidemic typhus occurring years after the primary infection, where *R. prowazekii* persists in the lymphoid tissue. * **Weil-Felix Test:** A heterophile agglutination test used for diagnosis. Epidemic typhus shows a positive reaction with **OX-19**. * **Drug of Choice:** **Doxycycline** is the gold standard treatment for all rickettsial infections. * **Vector Mnemonic:** Remember **"Louse-Prowazekii"** (Epidemic) vs. **"Flea-Typhi"** (Endemic).
Explanation: ### Explanation **Correct Answer: A. Period of communicability is 2 days after the last vesicle has crusted.** **Why Option A is the Correct Answer (The Exception):** In Varicella (Chickenpox), the period of communicability begins **1–2 days before** the appearance of the rash and continues until all lesions have **crusted (scabbed)**. Once the vesicles have crusted, the patient is no longer infectious. Therefore, the statement that communicability lasts until "2 days after the last vesicle has crusted" is medically incorrect. **Analysis of Other Options:** * **Option B:** Varicella is characterized by **pleomorphism**. This means that because the rash appears in rapid crops over 3–4 days, all stages of the lesion (papules, vesicles, and crusts) can be seen simultaneously in the same anatomical area. * **Option C:** Varicella is highly contagious. The **Secondary Attack Rate (SAR)** in household contacts who are susceptible is approximately **90%**, making it one of the most infectious diseases. * **Option D:** The rash of chickenpox has a **centripetal distribution**. It starts on the trunk and spreads to the face and limbs, but it characteristically affects the **flexor surfaces** and skin folds more than the extensor surfaces (unlike Smallpox). **High-Yield Clinical Pearls for NEET-PG:** * **Incubation Period:** Typically 14–16 days (Range: 10–21 days). * **Dew-drop on a rose petal:** Classic description of the varicella vesicle (clear fluid on an erythematous base). * **Starry Sky Appearance:** Refers to the pleomorphic nature of the rash. * **Smallpox vs. Chickenpox:** Smallpox rash is centrifugal (more on extremities), deep-seated, and all lesions in one area are at the same stage of development. * **Congenital Varicella Syndrome:** Occurs if the mother is infected in the first 20 weeks of pregnancy; characterized by cicatricial skin scarring and limb hypoplasia.
Epidemiology of NCDs
Practice Questions
Cardiovascular Disease Prevention
Practice Questions
Diabetes Control Program
Practice Questions
Cancer Screening and Control
Practice Questions
Chronic Respiratory Diseases
Practice Questions
Mental Health Program
Practice Questions
Blindness Control Program
Practice Questions
Accident and Injury Prevention
Practice Questions
NCD Risk Factor Surveillance
Practice Questions
National Program for Prevention and Control of Cancer, Diabetes, CVD, and Stroke
Practice Questions
Oral Health Program
Practice Questions
Geriatric Health Issues
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free